Results 31 to 40 of about 11,937 (148)
Allergy, Asthma & Clinical Immunology, 2008 This review focuses on aspirin-exacerbated asthma (AEA). The review includes historical perspective of aspirin, prevalence, pathogenesis, clinical features and treatment of AEA.
Varghese Mathew, Lockey Richard F
doaj +1 more source
The beneficial effects of Montelukast against 2,3,7,8-tetrachlorodibenzo- p -dioxin toxicity in female reproductive system in rats [PDF]
Acta Cirúrgica Brasileira, 2016 PURPOSE: To determine the toxic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on reproductive system and the beneficial effects of Montelukast (ML) with histological and biochemical analysis.
Rauf Melekoglu +4 more
doaj +1 more source
Churg-Strauss vasculitis in patient who received montelukas [PDF]
Vojnosanitetski Pregled, 2018 Introduction. Montelukast is a selective leukotriene receptor antagonist. One of side effects of this drug class is the Churg-Strauss syndrome (CSS).
Ćupurdija Vojislav +5 more
doaj +1 more source
Leukotriene receptor antagonists for eczema [PDF]
Cochrane Database of Systematic Reviews, 2018 Eczema is a common, chronic, inflammatory skin condition that is frequently associated with atopic conditions, including asthma. Leukotriene receptor antagonists (LTRAs) have a corticosteroid-sparing role in asthma, but their role in eczema remains controversial.
Leila, Ferguson +6 more
openaire +2 more sources
Frontiers in PharmacologyMultiple Sclerosis (MS) is a multifactorial autoimmune disease of the central nervous system (CNS). It is characterized by a heightened activation of the immune system with ensuing inflammation, demyelination and neurodegeneration with consequences such ...
Frank Pietrantonio +4 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are two highly prevalent human diseases caused by excessive fat deposition in the liver.
Stefano Fiorucci +15 more
doaj +1 more source
Phospholipid derived mediators and glomerulonephritis
Mediators of Inflammation, 1993 The contributions made by the various eicosanoids, PAF, the HETES and the lipoxins to the pathophysiology of glomerulonephritis is reviewed. A case can be made for clinical trials of PAF, leukotriene and thromboxane antagonists.
E. N. Wardle
doaj +1 more source
Leukotrienes in Atherosclerosis: New Target Insights and Future Therapy Perspectives
Mediators of Inflammation, 2009 Atherosclerosis represents an important chronic inflammatory process associated with several pathophysiological reactions in the vascular wall. The arachidonic acid, released by phospholipase A2, is an important substrate for the production of a group of
Graziano Riccioni +4 more
doaj +1 more source
MONTELUKAST IN TREATING ALLERGIC DISEASES
Педиатрическая фармакология, 2006 Anti inflammatory medications are the basis for pathogenetic treatment of allergic diseases. The review covers description of the most studied and efficient medication of leukotriene receptors' antagonist category montelukast.
T.V. Kulichenko
doaj +2 more sources
Update on leukotriene receptor antagonists in preschool children wheezing disorders
Italian Journal of Pediatrics, 2012 Asthma is the most common chronic disease in young children. About 40% of all preschool children regularly wheeze during common cold infections. The heterogeneity of wheezing phenotypes early in life and various anatomical and emotional factors unique to
Montella Silvia +5 more
doaj +1 more source